1029693

Mezgebe Berhe, MD — FEI 3013631687

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 29, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)